Ivan Shterev Donev (I S Donev, Ivan Donev, I Donev)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Venues

Cancer reports (Hoboken, N.J.)

Biomedicines

Current oncology (Toronto, Ont.)

Clinical and experimental immunology

This page only lists publications with an associated author ORCID identifier.

Publications

R Gencheva, M Petrova, P Kraleva, S Hadjidekova, Maria Atanasova Radanova, N Conev, D Stoyanov, J Arabadjiev, E Tazimova, S Bachurska, M Eneva, M Tsvetkova, G Zhbantov, T Karanikolova, D Manov, A Ivanova, M Taushanova-Hadjieva, R Staneva, E Dimitrova, Ivan Shterev Donev
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting. Cancer reports (Hoboken, N.J.) (2023)
R Gencheva, M Petrova, P Kraleva, S Hadjidekova, Maria Atanasova Radanova, N Conev, D Stoyanov, J Arabadjiev, E Tazimova, S Bachurska, M Eneva, M Tsvetkova, G Zhbantov, T Karanikolova, D Manov, A Ivanova, M Taushanova-Hadjieva, R Staneva, E Dimitrova, Ivan Shterev Donev
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting. Cancer reports (Hoboken, N.J.) (2023)
Urška Janžič, Nina Turnšek, Mircea Dediu, Ivan Shterev Donev, Roxana Lupu, Gabriela Teodorescu, Tudor E Ciuleanu, Adam Płużański
Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT). Current oncology (Toronto, Ont.) 29 (8) (2022)
Maria Radanova, Mariya Levkova, Galya Mihaylova, Rostislav Manev, Margarita Maneva, Rossen Hadgiev, Nikolay Conev, Ivan Shterev Donev
Single Nucleotide Polymorphisms in microRNA Genes and Colorectal Cancer Risk and Prognosis. Biomedicines 10 (1) (2022)
M P Petrova, Ivan Shterev Donev, Maria Atanasova Radanova, M I Eneva, E G Dimitrova, G N Valchev, V T Minchev, M S Taushanova, M V Boneva, T S Karanikolova, R B Gencheva, G A Zhbantov, A I Ivanova, C V Timcheva, B P Pavlov, V G Megdanova, B S Robev, N V Conev
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer. Clinical and experimental immunology 202 (3) (2020)

Ivan Shterev Donev.css-eqlu8i{font-size:small;padding-left:4px;} (I S Donev, Ivan Donev, I Donev)

Publication Activity (10 Years)

Top Topics

Top Venues

Ivan Shterev Donev (I S Donev, Ivan Donev, I Donev)